Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity TrialFrancesco Schettini, Daniele Generali, Manuela Milani et al.|Frontiers in Oncology|2021Cited by 19
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the “MOZART” prospective observational studyFrancesco Schettini, Daniele Generali, Marianna Sirico et al.|The Oncologist|2024Cited by 6
Next-Generation Sequencing-Based Evaluation of the Actionable Mutational Landscape in Solid Tumors: the “MOZART” Prospective Observational StudyFrancesco Schettini, Daniele Generali, Marianna Sirico et al.|Research Square|2024Cited by 0